These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6880726)

  • 21. Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects.
    Monaco F; Riccio A; Benna P; Covacich A; Durelli L; Fantini M; Furlan PM; Gilli M; Mutani R; Troni W; Gerna M; Morselli PL
    Neurology; 1976 Oct; 26(10):936-73. PubMed ID: 986584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Overnight fall in the serum level of carbamazepine (author's transl)].
    Fröscher W; Eichelbaum M; Gugler R; Baur MP
    Nervenarzt; 1979 Mar; 50(3):171-8. PubMed ID: 571537
    [No Abstract]   [Full Text] [Related]  

  • 24. Circadian effect on carbamazepine kinetics in rat.
    Bruguerolle B; Valli M; Bouyard L; Jadot G; Bouyard P
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):189-93. PubMed ID: 7030746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine-induced tics.
    Robertson PL; Garofalo EA; Silverstein FS; Komarynski MA
    Epilepsia; 1993; 34(5):965-8. PubMed ID: 8404753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma.
    McKauge L; Tyrer JH; Eadie MJ
    Ther Drug Monit; 1981; 3(1):63-70. PubMed ID: 7233491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine serum levels in children with epilepsy: a micro immuno-assay technique.
    Forsythe WI; Prendergast MP; Toothill C; Broughton PM
    Dev Med Child Neurol; 1979 Aug; 21(4):441-7. PubMed ID: 118072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients.
    Morselli PL; Monaco F; Gerna M; Recchia M; Riccio A
    Epilepsia; 1975 Dec; 16(5):759-64. PubMed ID: 1222752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
    Macphee GJ; Butler E; Brodie MJ
    Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saliva carbamazepine and phenytoin level monitoring.
    Rylance GW; Moreland TA
    Arch Dis Child; 1981 Aug; 56(8):637-40. PubMed ID: 7271302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steady-state carbamazepine plasma concentration-dose ratios in epileptic patients.
    Sánchez A; Durán JA; Serrano JS
    Clin Pharmacokinet; 1986; 11(5):411-4. PubMed ID: 3780114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyponatraemia during carbamazepine therapy in children.
    Koivikko MJ; Välikangas SL
    Neuropediatrics; 1983 May; 14(2):93-6. PubMed ID: 6877534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability?
    Hartley R; Aleksandrowicz J; Ng PC; McLain B; Bowmer CJ; Forsythe WI
    Br J Clin Pract; 1990 Jul; 44(7):270-3. PubMed ID: 2206824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asterixis associated with carbamazepine.
    Terzano MG; Salati MR; Gemignani F
    Acta Neurol Belg; 1983; 83(3):158-65. PubMed ID: 6613518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.